the aid library

LIST OPTIONS

Filter

1964

Download (670)

View PDF (971)

Injection providers' guide for safe injections

World Health Organization WHO (2017) C_WHO

Download (603)

View PDF (1073)

SSI Prevention - CORRECT AND SAFE SURGICAL ANTIBIOTIC PROPHYLAXIS

Surgical Unit-based Safety Program World Health Organisation (WHO) (2018) C_WHO

Download (585)

View PDF (1144)

SSI Prevention – PATIENT PREPARATION : BATHING AND HAIR REMOVAL

Surgical Unit-based Safety Program World Health Organisation (WHO) (2018) C_WHO

Download (519)

View PDF (1216)

SSI Prevention – SURGICAL SITE SKIN PREPARATION AND SURGICAL HAND PREPARATION

Surgical Unit-based Safety Program World Health Organisation (WHO) (2018) C_WHO

Download (473)

View PDF (1195)

SUSP SSI prevention measures Poster

Surgical Unit-based Safety Programme (SUSP) World Health Organisation (WHO) (2018) C_WHO

Protection of health and safety of health workers. Checklist for healthcare facilities

World Health Organization WHO (2020) C_WHO

This checklist is the first step in identifying and prioritizing areas of action for improving the protection of health and safety of health workers in line with WHO–ILO Global Framework for National Occupational Health Programmes for Health Workers. It is designed to be filled out in discussio... more

WHO aircraft disinsection methods and procedures

World Health Organization WHO (2021) C_WHO

Download (151)

View PDF (215)

Guideline for Disinfection and Sterilization in Healthcare Facilities

Centers for Disease Control and Prevention (CDC) (2019) C_CDC

The Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008, presents evidence- based recommendations on the preferred methods for cleaning, disinfection and sterilization of patient- care medical devices and for cleaning and disinfecting the healthcare environment. This docume... more

FAQs: Waste Management for COVID-19 in Healthcare Settings for Africa
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

Health care waste can be difficult to treat and dispose of safely. The environmental and health impacts of waste put extra pressure on resources. Therefore, it is important to try and reduce the quantities of waste wherever possible. Ensure waste is segregated properly at the point of disposal. It i... more

External Link

Poorly Designed PPE a Global Problem forWomen HealthWorkers

Kuehn, B.M. (2022) C1

Download (199)

View PDF (277)

Fit for women? Safe and decent PPE for women health and care workers

Women for Global Health WGH (2021) CC

One of the many gender inequities in the health and care workforce that COVID-19 has exposed is around the fit and design of Personal Protective Equipment (PPE). The rapid onset and scale of COVID-19 led to shortages of PPE in most countries, causing preventable infection and mortality among healthc... more

Download (293)

View PDF (298)

Fit for women? Safe and decent PPE for women health and care workers. Excecutive Summary

Women for Global Health WGH (2022) CC

Apto para mujeres? Mejora del equipo de protección personal (EPP) para las mujeres trabajadoras de la salud y el cuidado

Women for Global Health WGH (2022) CC

Una de las muchas desigualdades de género en el personal sanitario y asistencial que COVID-19 ha puesto de manifiesto es la relativa al ajuste y el diseño de los equipos de protección individual (EPP). La rápida aparición y la escala de COVID-19 condujeron a la escasez de EPP en la mayoría de ... more

Adaptés aux femmes? EPI surs et décents pour les femmes dans le secteur de la santé des soins

Women for Global Health WGH (2022) CC

Janvier 2022. L'une des nombreuses inégalités entre les sexes dans le secteur de la santé et des soins que COVID-19 a révélées concerne l'ajustement et la conception des équipements de protection individuelle (EPI). L'apparition rapide et l'ampleur de COVID-19 ont entraîné des pénuries d'... more

Download (193)

View PDF (243)

Fit for women? Safe and decent PPE for women health and care workers, Annex (Questionnaire)

Women for Global Health WGH (2021) CC

External Link

How to prevent resistant bacteria in hospital facilities. Video

Pan American Health Organisation PAHO (2021) C_WHO

How do they work in an ICC to prevent or mitigate nosocomial infections? Are you clear that we can all do something to avoid them? A simple hand wash can make a difference. Inés Lavega has a degree in nursing and worked for more than 8 years at the CTI of Hospital Maciel, the first public hospit... more

External Link

How an ICU works to prevent or treat hospital-acquired infections

Pan American Health Organisation PAHO (2021) C_WHO

Did you know that they are part of Antimicrobial Resistance? Are you clear that we can all do something to avoid them? Marcelo Barbato, intensive care physician and Director of the ICU at Hospital Maciel, the first public hospital in Uruguay with a long history in infection control, tells us.

Download (409)

View PDF (342)

Decontamination and reprocessing of medical devices for health care facilities: aide-memoire

World Health Organization WHO (2022) CC

Decontamination of medical devices plays an important role in the prevention of health care-associated infections. It includes cleaning, disinfection and/or sterilization. The processes involved in decontamination are complex, require specific infrastructure and equipment, and involve several sequen... more

Community Engagement During Public Health Emergencies Like COVID-19: An Action Framework and Toolkit

Bangladesh Red Crescent Society; BRAC; Government of Bangladesh; UN Children's Fund UNICEF; UN Women; World Health Organization WHO (2023) CC

This handbook offers a simple framework of action for actors in local government, and in particular, health leaders such as Civil Surgeons (CSs) and Upazila Health and Family Planning Officers (UHFPQOs), to take ownership and leadership to combat COVID-19 at each district and upazila respectively, w... more

Download (284)

View PDF (380)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

FAQs: Waste Management for COVID-19 in Healthcare Settings for Africa recommended

FAQs: Waste Management for COVID-19 in Healthcare Settings for Africa
recommended